Volume Alert: Novo Nordisk trades in sympathy with Sanofi (NVO)

Posted in General 
June 26th, 2009

Novo Nordisk AS (NYSE: NVO) shares are down about 4% and have traded a session’s worth of average volume in the first hour of the session. The stock is trading in sympathy with Sanofi Aventis (NYSE: SNY). Both companies are manufacturers of long-acting insulin products for treatment of diabetes. The worry is that there may be negative headlines coming soon in a major medical journal that may show an increased cancer risk associated with Sanofi’s Lantus insulin treatment.  — Mike Tarsala

Comments are closed

-->